Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $244M | $2.52B | $207M | $184M | $231M | $896.00B |
| Revenue (TTM) | $83M | $902M | $90M | $135M | $85M | $280.33B |
| Net Income (TTM) | $19M | $169M | $14M | $16M | $16M | $57.05B |
| Gross Margin | 69.0% | 73.6% | 54.7% | 54.3% | 65.1% | 60.0% |
| Operating Margin | 28.9% | 24.3% | 7.0% | 14.1% | 22.5% | 25.9% |
| Forward P/E | 12.7x | 11.5x | 11.8x | 11.0x | 11.3x | 14.4x |
| Total Debt | $30M | $327M | $52M | $70M | $2M | $942.38B |
| Cash & Equiv. | $6M | $185M | $119M | $26M | $8M | $343.34B |
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Virginia National B… (VABK) | 100 | 178.2 | +78.2% |
| NBT Bancorp Inc. (NBTB) | 100 | 156.6 | +56.6% |
| Citizens Community … (CZWI) | 100 | 312.8 | +212.8% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| National Bankshares… (NKSH) | 100 | 127.0 | +27.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VABK is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.48, yield 3.1%
- Lower volatility, beta 0.48, Low D/E 16.2%, current ratio 3.53x
- Beta 0.48, yield 3.1%, current ratio 3.53x
- Beta 0.48 vs JPM's 0.94, lower leverage
NBTB ranks third and is worth considering specifically for growth.
- 10.4% NII/revenue growth vs CZWI's -9.4%
CZWI is the clearest fit if your priority is momentum.
- +52.1% vs NBTB's +18.3%
MNSB is the clearest fit if your priority is bank quality.
- NIM 3.1% vs JPM's 2.2%
- Lower P/E (11.0x vs 11.3x)
NKSH is the clearest fit if your priority is growth exposure.
- Rev growth 7.9%, EPS growth 100.8%
- 4.2% yield, vs JPM's 1.9%
JPM has the current edge in this matchup, primarily because of its strength in long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs CZWI's 149.0%
- PEG 0.81 vs VABK's 3.36
- Efficiency ratio 0.3% vs CZWI's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs CZWI's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs CZWI's -9.4% | |
| Value | Lower P/E (11.0x vs 11.3x) | |
| Quality / Margins | Efficiency ratio 0.3% vs CZWI's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.48 vs JPM's 0.94, lower leverage | |
| Dividends | 4.2% yield, vs JPM's 1.9% | |
| Momentum (1Y) | +52.1% vs NBTB's +18.3% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CZWI's 0.5% |
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VABK leads in 1 of 6 categories
MNSB leads 1 • CZWI leads 1 • NBTB leads 0 • NKSH leads 0 • JPM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VABK leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3363.8x VABK's $83M. VABK is the more profitable business, keeping 23.1% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $83M | $902M | $90M | $135M | $85M | $280.3B |
| EBITDAEarnings before interest/tax | $26M | $241M | $9M | $23M | $20M | $81.4B |
| Net IncomeAfter-tax profit | $19M | $169M | $14M | $16M | $16M | $57.0B |
| Free Cash FlowCash after capex | $21M | $225M | $11M | $11M | $17M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +69.0% | +73.6% | +54.7% | +54.3% | +65.1% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +28.9% | +24.3% | +7.0% | +14.1% | +22.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +23.1% | +18.8% | +16.0% | +11.5% | +18.6% | +20.4% |
| FCF MarginFCF ÷ Revenue | +24.9% | +24.9% | +12.4% | +7.9% | +20.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +31.0% | +39.5% | +63.0% | +120.9% | +91.7% | +16.0% |
Valuation Metrics
MNSB leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, VABK trades at a 21% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs NKSH's 140.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $244M | $2.5B | $207M | $184M | $231M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $268M | $2.7B | $140M | $227M | $225M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 12.68x | 14.47x | 14.70x | 14.16x | 14.59x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.54x | 11.79x | 11.03x | 11.28x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 3.36x | 2.06x | 2.90x | — | 140.16x | 0.90x |
| EV / EBITDAEnterprise value multiple | 11.13x | 11.03x | 15.69x | 11.90x | 11.74x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.93x | 2.90x | 2.29x | 1.35x | 2.71x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.32x | 1.29x | 1.11x | 0.87x | 1.25x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 11.76x | 11.49x | 19.90x | 17.26x | 15.27x | 8.88x |
Profitability & Efficiency
Evenly matched — NKSH and JPM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for MNSB. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.0% | +9.5% | +7.8% | +7.3% | +9.0% | +15.9% |
| ROA (TTM)Return on assets | +1.2% | +1.1% | +0.8% | +0.7% | +0.9% | +1.3% |
| ROICReturn on invested capital | +9.0% | +7.9% | +2.0% | +5.0% | +8.4% | +4.5% |
| ROCEReturn on capital employed | +2.6% | +2.4% | +0.6% | +6.0% | +1.9% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 6 | 5 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.16x | 0.17x | 0.28x | 0.32x | 0.01x | 2.60x |
| Net DebtTotal debt minus cash | $24M | $142M | -$67M | $43M | -$6M | $599.0B |
| Cash & Equiv.Liquid assets | $6M | $185M | $119M | $26M | $8M | $343.3B |
| Total DebtShort + long-term debt | $30M | $327M | $52M | $70M | $2M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.94x | 1.05x | 0.16x | 0.31x | 0.64x | 0.74x |
Total Returns (Dividends Reinvested)
CZWI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,813 for MNSB. Over the past 12 months, CZWI leads with a +52.1% total return vs NBTB's +18.3%. The 3-year compound annual growth rate (CAGR) favors CZWI at 36.4% vs MNSB's 4.2% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.2% | +17.6% | +24.3% | +26.5% | +12.3% | -0.5% |
| 1-Year ReturnPast 12 months | +24.1% | +18.3% | +52.1% | +37.2% | +42.4% | +21.8% |
| 3-Year ReturnCumulative with dividends | +61.9% | +48.5% | +153.7% | +13.1% | +37.2% | +138.2% |
| 5-Year ReturnCumulative with dividends | +50.9% | +44.4% | +69.0% | +18.1% | +24.3% | +118.2% |
| 10-Year ReturnCumulative with dividends | +146.5% | +108.5% | +149.0% | +135.4% | +54.9% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +17.4% | +14.1% | +36.4% | +4.2% | +11.1% | +33.6% |
Risk & Volatility
Evenly matched — VABK and NBTB each lead in 1 of 2 comparable metrics.
Risk & Volatility
VABK is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 99.8% from its 52-week high vs NKSH's 90.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.76x | 0.50x | 0.60x | 0.73x | 0.94x |
| 52-Week HighHighest price in past year | $48.58 | $48.27 | $22.62 | $25.17 | $40.00 | $337.25 |
| 52-Week LowLowest price in past year | $36.48 | $39.20 | $12.83 | $17.86 | $24.74 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +92.6% | +99.8% | +94.9% | +99.0% | +90.8% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 63.0 | 63.1 | 51.2 | 65.3 | 55.1 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 6K | 266K | 41K | 45K | 49K | 7.0M |
Analyst Outlook
Evenly matched — NKSH and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NBTB as "Hold", CZWI as "Buy", MNSB as "Hold", NKSH as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -4.5% for NBTB (target: $46). For income investors, NKSH offers the higher dividend yield at 4.16% vs MNSB's 1.60%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $46.00 | — | — | — | $339.75 |
| # AnalystsCovering analysts | — | 10 | 2 | 1 | 4 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +3.0% | +1.7% | +1.6% | +4.2% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 13 | 6 | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | $1.40 | $1.43 | $0.37 | $0.40 | $1.51 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | +3.0% | +2.4% | 0.0% | +3.9% |
VABK leads in 1 of 6 categories (Income & Cash Flow). MNSB leads in 1 (Valuation Metrics). 3 tied.
VABK vs NBTB vs CZWI vs MNSB vs NKSH vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VABK or NBTB or CZWI or MNSB or NKSH or JPM a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). Virginia National Bankshares Corporation (VABK) offers the better valuation at 12. 7x trailing P/E, making it the more compelling value choice. Analysts rate Citizens Community Bancorp, Inc. (CZWI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
On trailing P/E, Virginia National Bankshares Corporation (VABK) is the cheapest at 12.
7x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, MainStreet Bancshares, Inc. is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus National Bankshares, Inc. 's 140. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +18. 1% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NKSH's +54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
By beta (market sensitivity over 5 years), Virginia National Bankshares Corporation (VABK) is the lower-risk stock at 0.
48β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 97% more volatile than VABK relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
Virginia National Bankshares Corporation (VABK) is the more profitable company, earning 23.
1% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 23. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VABK leads at 28. 9% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VABK or NBTB or CZWI or MNSB or NKSH or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus National Bankshares, Inc. 's 140. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, MainStreet Bancshares, Inc. (MNSB) trades at 11. 0x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 3. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — VABK or NBTB or CZWI or MNSB or NKSH or JPM?
All stocks in this comparison pay dividends.
National Bankshares, Inc. (NKSH) offers the highest yield at 4. 2%, versus 1. 6% for MainStreet Bancshares, Inc. (MNSB).
09Is VABK or NBTB or CZWI or MNSB or NKSH or JPM better for a retirement portfolio?
For long-horizon retirement investors, Virginia National Bankshares Corporation (VABK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
48), 3. 1% yield, +146. 5% 10Y return). Both have compounded well over 10 years (VABK: +146. 5%, NKSH: +54. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VABK and NBTB and CZWI and MNSB and NKSH and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.